The HAS / CNEDiMTS route explained science, law, and real-world decisions France operates one of the most structured and evidence-based reimbursement systems for medical devices in Europe. Access is not …
Tag:
#HealthEconomics
-
-
How to Use German NUB Reimbursement Without Getting Trapped After nearly two decades of operational data, one conclusion is unavoidable: German NUB reimbursement is not a neutral innovation gateway. It …
-
Introduction: How NICE Approval in the NHS Is Now Secured Securing approval from the National Institute for Health and Care Excellence (NICE) remains one of the most decisive milestones for …
-
Why SNOMED CT and dm+d changes matter fundamentally for Digital Health, MedTech, and Biotech companies Between 2025 and 2026, the NHS will quietly implement one of the most consequential digital …
-
Denmark is often described as a “DRG country”. That is technically true but strategically misleading. On the surface, the Danish DRG system looks familiar: national groupers, published tariffs, annual updates, …
-
Why KVÅ Procedure Reimbursement Matters in Sweden KVÅ procedure reimbursement is one of the most powerful—but often misunderstood—mechanisms in the Swedish healthcare system. What appears to be a simple six-character …
-
News
The NHS 10-Year Plan Paradox: How to author creative reimbursement. How Innovation Risks Becoming a Bottleneck in a Decade of “Transformation”
The Promise and the Paradox The UK Government’s 10-Year Health Plan for England (2025–2035) presents itself as a blueprint for a modernised NHS—one that is digitally enabled, outcomes-measured, genomically informed, …
-
How Scientific Abstracts and Reimbursement Really Connect in MedTech and Digital Health This article explains how scientific abstracts and reimbursement are linked in the MedTech, IVD, and digital health sectors. …